NCT04882371View on ClinicalTrials.gov

Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

May 1, 2020

Study Completion Date

August 1, 2020

Conditions

Breast CancerChemotherapy Effect

Interventions

DRUG

Chemotherapy

Neoadjuvant Chemotherapy for Breast Cancer

DIAGNOSTIC_TEST

Magnetic Resonance Imaging (MRI)

Performed contrasted MRI for evaluate response of neoadjuvant chemotherapy

DIAGNOSTIC_TEST

Positron emission tomography - Copmputer Tomography (PET-CT)

Performed contrasted PET-CT for evaluate response of neoadjuvant chemotherapy

Trial Locations (1)

34100

Istanbul Medeniyet University Goztepe City Hospital, Istanbul

All Listed Sponsors

lead

Cem Ilgin Erol

OTHER

NCT04882371 - Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer | Biotech Hunter | Biotech Hunter